Now showing items 1-1 of 1

    • The ß2-adrenergic receptor is a molecular switch for neuroendocrine transdifferentiation of prostate cancer cells 

      Braadland, PR; Ramberg, H; Grytli, HH; Urbanucci, A; Nielsen, HK; Guldvik, IJ; Engedal, A; Ketola, K; Wang, W; Svindland, A; Mills, IG; Bjartell, A; Tasken, KA (American Association for Cancer Research (AACR), 2019)
      The incidence of treatment-related neuroendocrine prostate cancer (t-NEPC) is rising as more potent drugs targeting the androgen signaling axis are clinically implemented. Neuroendocrine transdifferentiation (NEtD), an ...
      Tieteelliset aikakauslehtiartikkelit